Size does matter: The role of decompressive craniectomy extent for outcome after aneurysmal subarachnoid hemorrhage.


Journal

European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311

Informations de publication

Date de publication:
07 2021
Historique:
revised: 16 03 2021
received: 15 02 2021
accepted: 17 03 2021
pubmed: 25 3 2021
medline: 13 8 2021
entrez: 24 3 2021
Statut: ppublish

Résumé

In previous studies in patients with traumatic brain injury and ischemic stroke, the size of decompressive craniectomy (DC) was reported to be paramount with regard to patient outcomes. We aimed to identify the impact of DC size on treatment results in individuals with aneurysmal subarachnoid hemorrhage (SAH). The extent of DC in 232 patients with SAH who underwent bifrontal or hemicraniectomy between January 2003 and December 2015 was analyzed using semi-automated surface measurements. The study endpoints were course of intracranial pressure (ICP) treatment after DC, occurrence of cerebral infarcts, in-hospital mortality, and unfavorable outcome at 6 months (defined as modified Rankin scale score >3). The associations of DC size with the study endpoints were adjusted for DC timing, patient age, clinical and radiographic severity of SAH, aneurysm location, and treatment modality. The mean DC surface area was 100.9 (±45.8) cm This is the first study showing the impact of DC size on postoperative ICP control and patient outcome in the context of SAH; specifically, a large craniectomy flap (>105 cm

Sections du résumé

BACKGROUND AND PURPOSE
In previous studies in patients with traumatic brain injury and ischemic stroke, the size of decompressive craniectomy (DC) was reported to be paramount with regard to patient outcomes. We aimed to identify the impact of DC size on treatment results in individuals with aneurysmal subarachnoid hemorrhage (SAH).
METHODS
The extent of DC in 232 patients with SAH who underwent bifrontal or hemicraniectomy between January 2003 and December 2015 was analyzed using semi-automated surface measurements. The study endpoints were course of intracranial pressure (ICP) treatment after DC, occurrence of cerebral infarcts, in-hospital mortality, and unfavorable outcome at 6 months (defined as modified Rankin scale score >3). The associations of DC size with the study endpoints were adjusted for DC timing, patient age, clinical and radiographic severity of SAH, aneurysm location, and treatment modality.
RESULTS
The mean DC surface area was 100.9 (±45.8) cm
CONCLUSION
This is the first study showing the impact of DC size on postoperative ICP control and patient outcome in the context of SAH; specifically, a large craniectomy flap (>105 cm

Identifiants

pubmed: 33760316
doi: 10.1111/ene.14835
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2200-2207

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.

Références

Darkwah Oppong M, Gumus M, Pierscianek D, et al. Aneurysm rebleeding before therapy: a predictable disaster? J Neurosurg. 2018;1-8.
Jabbarli R, Oppong MD, Dammann P, et al. Time is brain! analysis of 245 cases with decompressive craniectomy due to subarachnoid hemorrhage. World Neurosurg. 2017;98:689-694.
Buschmann U, Yonekawa Y, Fortunati M, Cesnulis E, Keller E. Decompressive hemicraniectomy in patients with subarachnoid hemorrhage and intractable intracranial hypertension. Acta Neurochir. 2007;149:59-65.
Otani N, Takasato Y, Masaoka H, et al. Surgical outcome following decompressive craniectomy for poor-grade aneurysmal subarachnoid hemorrhage in patients with associated massive intracerebral or Sylvian hematomas. Cerebrovasc Dis. 2008;26:612-617.
Schirmer CM, Hoit DA, Malek AM. Decompressive hemicraniectomy for the treatment of intractable intracranial hypertension after aneurysmal subarachnoid hemorrhage. Stroke. 2007;38:987-992.
Buhler D, Azghandi S, Schuller K, Plesnila N. Effect of decompressive craniectomy on outcome following subarachnoid hemorrhage in mice. Stroke. 2015;46:819-826.
Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870-947.
Alotaibi NM, Elkarim GA, Samuel N, et al. Effects of decompressive craniectomy on functional outcomes and death in poor-grade aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Neurosurg. 2017;127:1315-1325.
Darkwah Oppong M, Golubovic J, Hauck EF, Wrede KH, Sure U, Jabbarli R. Decompressive craniectomy in aneurysmal subarachnoid hemorrhage: Who and when? - A systematic review and meta-analysis. Clin Neurol Neurosurg. 2020;199:106252.
Jabbarli R, Darkwah Oppong M, Roelz R, et al. The PRESSURE score to predict decompressive craniectomy after aneurysmal subarachnoid haemorrhage. Brain Commun. 2020;2:fcaa134.
Jiang JY, Xu W, Li WP, et al. Efficacy of standard trauma craniectomy for refractory intracranial hypertension with severe traumatic brain injury: a multicenter, prospective, randomized controlled study. J Neurotrauma. 2005;22:623-628.
Li G, Wen L, Yang X-F, Zheng X-J, Zhan R-Y, Liu W-G. Efficacy of large decompressive craniectomy in severe traumatic brain injury. Chin J Traumatol. 2008;11:253-256.
Millar K, Eljamel S. Does size and site matter in therapeutic decompressive craniectomy? A Laboratory-Based Experimental Study. World Neurosurg. 2016;95:441-446.
Schur S, Martel P, Marcoux J. Optimal bone flap size for decompressive craniectomy for refractory increased intracranial pressure in traumatic brain injury: taking the patient's head size into account. World Neurosurg. 2020;137:e430-e436.
Sedney CL, Julien T, Manon J, Wilson A. The effect of craniectomy size on mortality, outcome, and complications after decompressive craniectomy at a rural trauma center. J Neurosci Rural Pract. 2014;5:212-217.
Wagner S, Schnippering H, Aschoff A, Koziol JA, Schwab S, Steiner T. Suboptimum hemicraniectomy as a cause of additional cerebral lesions in patients with malignant infarction of the middle cerebral artery. J Neurosurg. 2001;94:693-696.
Holsgrove DT, Kitchen WJ, Dulhanty L, Holland JP, Patel HC. Intracranial hypertension in subarachnoid haemorrhage: outcome after decompressive craniectomy. Acta Neurochirur Suppl. 2014;119:53-55.
Molyneux AJ, Kerr RS. The future management of subarachnoid haemorrhage. J Neuroradiol. 2002;29:74-75.
Steiner T, Juvela S, Unterberg A, et al. European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis. 2013;35:93-112.
Jabbarli R, Pierscianek D, Rolz R, et al. Endovascular treatment of cerebral vasospasm after subarachnoid hemorrhage: more is more. Neurology. 2019;93:e458-e466.
van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604-607.
Teasdale GM, Drake CG, Hunt W, et al. A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. J Neurol Neurosurg Psychiatry. 1988;51:1457.
Darkwah Oppong M, Iannaccone A, Gembruch O, et al. Vasospasm-related complications after subarachnoid hemorrhage: the role of patients’ age and sex. Acta Neurochir. 2018;160:1393-1400.
Fisher CM, Roberson GH, Ojemann RG. Cerebral vasospasm with ruptured saccular aneurysm-the clinical manifestations. Neurosurgery. 1977;1:245-248.
D'Ambrosio AL, Sughrue ME, Yorgason JG, et al. Decompressive hemicraniectomy for poor-grade aneurysmal subarachnoid hemorrhage patients with associated intracerebral hemorrhage: clinical outcome and quality of life assessment. Neurosurgery. 2005;56(1):12-20.
Smith E, Carter B, Ogilvy C. Proposed use of prophylactic decompressive craniectomy in poor-grade aneurysmal subarachnoid hemorrhage patients presenting with associated large sylvian hematomas. Neurosurgery. 2002;51:117-124.discussion 124.
Sahuquillo J, Dennis JA. Decompressive craniectomy for the treatment of high intracranial pressure in closed traumatic brain injury. Cochrane Database Syst Rev. 2019;12:CD003983.
Hofmeijer J, Kappelle LJ, Algra A, et al. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol. 2009;8:326-333.
Juttler E, Schwab S, Schmiedek P, et al. Decompressive Surgery For The Treatment Of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial. Stroke. 2007;38:2518-2525.
Carney N, Totten AM, O'Reilly C, et al. Guidelines for the management of severe traumatic brain injury, Fourth Edition. Neurosurgery. 2017;80:6-15.
Hambock M, Hosmann A, Seemann R, et al. The impact of implant material and patient age on the long-term outcome of secondary cranioplasty following decompressive craniectomy for severe traumatic brain injury. Acta Neurochir. 2020;162:745-753.
Rashidi A, Sandalcioglu IE, Luchtmann M. Aseptic bone-flap resorption after cranioplasty - incidence and risk factors. PLoS One. 2020;15:e0228009.
Wirtz CR, Steiner T, Aschoff A, et al. Hemicraniectomy with dural augmentation in medically uncontrollable hemispheric infarction. Neurosurg Focus. 1997;2:E3. discussion 1 p following E3.
Harris L, Hill CS. Craniectomy size for subdural haematomas and the impact on brain shift and outcomes. Acta Neurochir. 2020;162:2019-2027.
Reid P, Say I, Shah S, et al. Effect of bone flap surface area on outcomes in decompressive hemicraniectomy for traumatic brain injury. World Neurosurg. 2018;119:e922-e927.

Auteurs

Ramazan Jabbarli (R)

Department of Neurosurgery and Spine Surgery, University Hospital of Essen, Essen, Germany.

Shi-Qing He (SQ)

Department of Neurosurgery and Spine Surgery, University Hospital of Essen, Essen, Germany.
Department of Neurosurgery, Affiliated Nanhua Hospital, Hengyang Medical College, University of South China, Hengyang, Hunan, China.

Marvin Darkwah Oppong (M)

Department of Neurosurgery and Spine Surgery, University Hospital of Essen, Essen, Germany.

Annika Herten (A)

Department of Neurosurgery and Spine Surgery, University Hospital of Essen, Essen, Germany.

Mehdi Chihi (M)

Department of Neurosurgery and Spine Surgery, University Hospital of Essen, Essen, Germany.

Daniela Pierscianek (D)

Department of Neurosurgery and Spine Surgery, University Hospital of Essen, Essen, Germany.

Philipp Dammann (P)

Department of Neurosurgery and Spine Surgery, University Hospital of Essen, Essen, Germany.

Ulrich Sure (U)

Department of Neurosurgery and Spine Surgery, University Hospital of Essen, Essen, Germany.

Karsten H Wrede (KH)

Department of Neurosurgery and Spine Surgery, University Hospital of Essen, Essen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH